← Issue №17/ week of Oct 25, 2026/Hepatology

Single-cell landscape of alcohol-related hepatitis reveals serum amyloid a hepatocytes as key drivers of disease pathogenesis.

From GI Signals issue №17: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology prospective cohort · n=30 · Oct 23, 2026 · Hepatology · IF 18.0

Single-cell landscape of alcohol-related hepatitis reveals serum amyloid a hepatocytes as key drivers of disease pathogenesis.

Basic sciencebasic sciencetranslationalbiomarkeralcohol-associated liver disease
Clinical takeawayNo clinical action yet: a mechanistic finding in human liver biopsies and organoid cultures, identifying SAA-FPR2 pathway as a potential therapeutic target.
What it foundCirculating serum amyloid A (SAA) levels were elevated in alcohol-related hepatitis (AH) and associated with reduced survival.
ContextThis study provides new insights into the cellular heterogeneity and dynamics in ALD progression, dissecting AH at a single-cell level.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Martínez-Álvarez A … Pose E · Hepatology · IF 18.0 · PubMed ↗Permalink
← Read the whole of issue №17 Every paper GI Signals surfaces gets a page like this one. All issues